Clinical Trials Logo
  1. Home
  2. Healthy Adult Subjects
  3. NCT05632211

A Study to Investigate the PK, Safety, and Tolerability Between AVT05, US and EU Simponi® in Healthy Adult Participants

Healthy Adult Subjects Clinical Trial

Official title:
A First-in-human, Randomized, Parallel Group, Double-blind, 3-arm Study to Investigate the Comparative PK, Safety, and Tolerability Between Subcutaneous AVT05, US-licensed Simponi®, and EU-approved Simponi® in Healthy Adult Participants

Clinical Trial Summary

Rationale: Alvotech is developing AVT05 globally as a proposed biosimilar to the reference product Simponi (golimumab) for subcutaneous (SC) use. This is a first-in-human (FIH) clinical study with AVT05. The study aims to demonstrate pharmacokinetic (PK) similarity of the proposed biosimilar test product AVT05 and the reference products EU approved Simponi and US-licensed Simponi, in addition to evaluating the safety and tolerability of AVT05, when administered as a single 50 mg/0.5 mL SC dose.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05632211
Study type Interventional
Source Alvotech Swiss AG
Contact
Status Completed
Phase Phase 1
Start date December 16, 2022
Completion date October 3, 2023
View Details
See also
  Status Clinical Trial Phase
Completed NCT03267732 - A Study to Evaluate the Pharmacokinetics in Participants After Dosing With Pegilodecakin (LY3500518) Phase 1
Completed NCT05040113 - A Study On Human Mass Balance And Biotransformation Phase 1
Completed NCT01433835 - Safety and Pharmacokinetics of Single Oral Doses of MBX-400 in Healthy Volunteers Phase 1
Completed NCT04029090 - A Study to Evaluate the Effect of MCI-186 at Therapeutic and Supra-Therapeutic Doses on the QT Interval(QT)/Corrected QT Interval(QTc) Interval in Healthy Subjects Phase 1
Completed NCT04586985 - Safety, Tolerability and Pharmacokinetics of FTX-6058 Phase 1
Completed NCT04481789 - Clinical Pharmacology Study of Oral Edaravone in Healthy Adult Males (Drug Interaction Study and Preliminary Regimen-Finding Study) Phase 1
Completed NCT06107205 - Bioequivalence of TTYP01 Tablets in Healthy Adult Subjects Phase 1
Completed NCT04629131 - Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TNM002 in Healthy Adults Phase 1
Completed NCT04203862 - A Study of NPC-22 in Healthy Adult Males Phase 1
Recruiting NCT05641181 - A Trial of CRB4101 in Healthy Subjects Phase 1
Not yet recruiting NCT06063291 - Single Ascending Oral Dose Phase 1 Study of ID11052 in Healthy Adult Subjects Phase 1
Completed NCT04521192 - Bioequivalence of Fluzoparib(SHR3162) Study on Healthy Chinese Adult Subjects Phase 1
Completed NCT04400123 - A Bioequivalence Study of Famitinib Malate on Healthy Chinese Volunteers Phase 1
Completed NCT04811469 - Safety, Tolerability and Pharmacokinetics of CBP-174 in Healthy Adults Phase 1
Completed NCT04291846 - A Food Effect Study of SHR1459 on Healthy Chinese Adult Subjects Phase 1
Completed NCT01364441 - Single-Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ONO-2952 in Healthy Adult Subjects Phase 1
Completed NCT02691702 - Multiple Dose Study Of BIIB118 (PF-05251749) In Healthy Volunteers Phase 1
Recruiting NCT05334043 - Pharmacokinetics and Bioavailability of Curcumin UP 30 Capsules in Healthy Adult Subjects Phase 1
Completed NCT04493281 - Bioequivalence Study of Oral Suspension and Intravenous Formulation of Edaravone in Healthy Adult Subjects Phase 1
Completed NCT01376063 - Study to Investigate the Interaction Between FG-4592 and Rosiglitazone in Healthy Adult Subjects Phase 1